Recent Price Movement and Market Context
The stock has been on a downward trajectory for the past four consecutive trading sessions, losing approximately 3.71% over this period. Despite outperforming its sector by 0.33% on the day it hit the new low, the overall trend remains subdued. TTK Healthcare is currently trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, signalling persistent bearish momentum.
In contrast, the broader market, represented by the Sensex, experienced a volatile session. After a sharp gap down opening of 1,710.03 points, the index recovered by 253.16 points to trade at 78,781.98, still down 1.82% on the day. The Sensex itself is trading below its 50-day moving average, although the 50DMA remains above the 200DMA, indicating mixed medium-term signals. Other indices such as NIFTY Realty and S&P BSE Realty also recorded new 52-week lows today, reflecting sector-specific pressures.
Long-Term Performance and Valuation Metrics
Over the past year, TTK Healthcare has delivered a negative return of 22.94%, significantly underperforming the Sensex, which posted a positive 7.97% return over the same period. The stock’s 52-week high was Rs.1,402, highlighting the extent of the decline from its peak.
From a valuation standpoint, the company trades at a Price to Book Value of 1.2, which is a premium relative to its peers’ historical averages. Its Return on Equity (ROE) stands at 6.5%, a modest figure that reflects limited profitability relative to shareholder equity. The Price/Earnings to Growth (PEG) ratio is elevated at 7.7, indicating that the stock’s price may not be fully justified by its earnings growth rate, which has been a mere 2.4% over the past year.
Momentum just kicked in! This Small Cap from the Auto - Trucks sector entered our list with explosive short-term signals. Catch the wave while it's still building!
- - Fresh momentum detected
- - Explosive short-term signals
- - Early wave positioning
Financial Performance and Operational Indicators
TTK Healthcare’s long-term growth has been modest, with net sales increasing at an annualised rate of 6.99% and operating profit growing at 15.42% over the last five years. The company’s half-year financials reveal some areas of concern: cash and cash equivalents have declined to Rs.600.89 crores, the lowest level recorded in recent periods, while the debtors turnover ratio has dropped to 7.40 times, signalling slower collection efficiency.
Non-operating income constitutes a significant portion of quarterly profit before tax (PBT), accounting for 80.43%, which may indicate reliance on income sources outside core business activities. Despite the company’s size, domestic mutual funds hold a negligible stake of just 0.01%, suggesting limited institutional confidence or interest at current price levels.
Comparative Performance and Market Position
In addition to underperforming the Sensex, TTK Healthcare has lagged behind the BSE500 index over the last three years, one year, and three months. This consistent underperformance across multiple time frames highlights challenges in maintaining competitive growth and shareholder returns.
On a positive note, the company maintains a low average debt-to-equity ratio of zero, reflecting a conservative capital structure with minimal leverage. This financial prudence may provide some stability amid market fluctuations.
Considering TTK Healthcare Ltd.? Wait! SwitchER has found potentially better options in Diversified and beyond. Compare this micro-cap with top-rated alternatives now!
- - Better options discovered
- - Diversified + beyond scope
- - Top-rated alternatives ready
Mojo Score and Analyst Ratings
TTK Healthcare currently holds a Mojo Score of 37.0, categorised as a Sell grade. This represents a downgrade from its previous Hold rating as of 21 July 2025. The company’s market capitalisation grade stands at 4, reflecting its mid-tier size within the diversified sector. The downgrade reflects a reassessment of the company’s growth prospects and financial metrics in light of recent performance trends.
Summary of Key Metrics
To summarise, TTK Healthcare’s stock has declined to Rs.878.2, its lowest level in 52 weeks, following a sustained period of negative returns and underperformance relative to the Sensex and sector indices. The company’s financial indicators reveal modest growth, limited profitability, and a conservative capital structure. Institutional interest remains minimal, and the stock trades at a premium valuation despite subdued earnings growth.
These factors collectively contribute to the current market sentiment and pricing levels observed in TTK Healthcare’s shares.
Limited Period Only. Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Get 72% Off →
